CERENOVUS California Compliance

CERENOVUS California Compliance

NOTICE: this information is provided pursuant to the requirements of Cal. Health & Safety Code § 119402 (S.B. 1765), which requires certain pharmaceutical and medical device companies doing business in California to make available their program for compliance with applicable federal and state laws and industry standards regulating the marketing and promotion of their products


CERENOVUS, (the "Company") have established a program designed to materially comply with applicable federal and state laws and industry standards relating to the marketing and promotion of its products. Additionally, the Company recognizes that adherence to these standards can be furthered through a compliance program that is informed by the Compliance Program Guidance for Pharmaceutical Manufacturers, published by the Office of Inspector General of the U.S. Department of Health and Human Services (the "OIG Guide"). The OIG Guide advises that effective compliance programs are comprised of seven elements. As described below, these elements form the basis of the Company's program for compliance with the standards regulating the marketing and promotion of its products.

II. Overview of Compliance Program

1. Written Policies and Procedures

The Company has written policies to assure substantial compliance with the applicable laws and regulations and standards governing the marketing and promotion of our products. Among these standards are recognized industry codes of conduct including the Code of Ethics on Interactions with Health Care Professionals (AdvaMed Code), published by the Advanced Medical Technology Association ("AdvaMed"). The Company has established written policies that govern activities involving communicating with customers about the appropriate use of our products including appropriate instruction, education, training, service and technical support required for the safe and effective use of our products. The Company also has policies governing activities involving the advancement of scientific and educational activities supporting medical research and education. These policies include:

Policies on Educational Grants and Research Grants

The Company may provide grants for specific educational purposes that benefit patients and customers. These may include, but are not limited to, continuing medical and paraprofessional education programs, fellowships provided to teaching institutions and similar organizations with a demonstrated commitment to scientific and technical education, and programs operated by organizations that provide high-quality, nationally recognized patient education. Funding of educational programs will generally be provided only to organizations and institutions and not to individual practitioners.

Research grants to support customer-initiated research may be provided for programs involving research in areas of legitimate interest to the company. All requests are subject to scientific review prior to funding approval.

Policy on Charitable Contributions and Patient Assistance

The Company will consider charitable contributions and requests for patient assistance in the areas of children's health, health care education, access to health care and community responsibility, consistent with the Company policies.

Policy on Travel Expense Reimbursement for CME, Promotional or Product Training Meetings

The Company will, with very limited exceptions that are in accordance with nationally recognized standards, not reimburse for travel and lodging expenses of attendees at promotional and educational programs.

The Company may reimburse attendees for their reasonable travel and lodging expenses associated with attendance at product training meetings. Product training meetings will be conducted in locations conducive to the exchange of information such as educational or conference settings. Where face-to-face or hands-on customer training is reasonably necessary for the safe and effective use of the Company's medical device products is required, the Company may provide training at company facilities, at independent teaching centers such as medical institutions, or in other appropriate clinical settings.

Policy on Business Meals

The Company may occasionally offer a modest meal, consistent with the standards of the AdvaMed Code as part of an educational presentation or a business discussion. Venues that feature entertainment or recreation, and attendance by spouses or guests, are not permitted.

Policy on the Provision of Educational and Practice-Related Items

On occasion, the Company representatives may provide items that benefit patients or serve a genuine educational function for Health Care Professionals, consistent with the standards of the AdvaMed Code.

Total Annual Dollar Limit for Meals and Educational or Practice-related Items

Each of the Companies, have established an annual limit of $2,500 for meals and educational items as the aggregate value of the items or activities that may be provided to California health care professionals pursuant to the requirements of Cal. Health & Safety Code § 119402 (S.B. 1765).

Policy Prohibiting Entertainment

It is the policy of the Company not to provide Entertainment (e.g. sporting events, golf outings, concerts, hunting, etc.) to customers.

2. Assigned Compliance Officer

The Company has appointed Health Care Compliance Officers. Our Health Care Compliance Officers have been empowered with appropriate authority to exercise independent judgment and has free and unencumbered access to senior management.

The Company has appointed Health Care Compliance Committees. The committees are comprised of the Company's Health Care Compliance Officers and members of the Company's management team.

3. Training.

The Company has an annual Health Care Compliance training process that includes testing and annual certification of appropriate employees. The training covers applicable guidelines governing our compliance program. Employees are also trained on the consequences of failure to comply with the requirements of the company's compliance program.

4. Communication.

The Company encourages open and candid discussion between management and employees regarding any compliance concerns. The Company employees are encouraged to report their concerns to their manager, to the Human Resources Department, to the Law Department or to the company's Health Care Compliance Officer.

5. Auditing and Monitoring.

The Company self-assesses and periodically audits its compliance with its policies and procedures.

6. Enforcement and Disciplinary Guidelines.

The Company will take disciplinary actions in response to violation of the company's compliance policies or procedures. The Company will conduct a fair and diligent investigation of matters that are brought to the company's attention in order to ensure the consistent application of the company's standards.

7. Responses To Detected Problems and Actions To Correct Issues.

The Company requires a prompt and diligent response to potential violations of the company's compliance program, including its standards regulating the marketing and promotion of our products. Actions in response to detected problems may include improving policies, procedures, training, communication and monitoring or may require disciplinary action to prevent future violations.

For a copy of this California Compliance Program, please call 1-877-889-3636. Provide your name, mailing address and request that a copy of the CERENOVUS California Compliance program be sent to you.


As part of the Company's ongoing efforts in the area of compliance, we have developed a Comprehensive Compliance Program that is designed to comply with applicable federal and state laws and industry standards relating to the marketing and promotion of our products. To our knowledge as of the date of this declaration, the Company is in compliance with our Comprehensive Compliance Program, as described here, and with California Health & Safety Code sections 119400-119402.

Dated: December 9, 2022